Cancer of Lung: Clinical Trials

4 trials for Cancer of Lung, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 completed. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Active not recruiting 2, Completed 2
Phase 11Active not recruiting 1

Follow Cancer of Lung: new trials by email Literature Review of Cancer of Lung trials Research Report on Cancer of Lung

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
JDQ443, TNO155, tislelizumab - KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 2Active not recruitingNovartis Pharmaceuticals3442021-02-242026-10-19
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma
UV1 vaccine + leukine, ipilimumab, nivolumab - Cancer, Cancer, Lung
Phase 2Active not recruitingÅslaug Helland1182020-05-042024-02-29
Study of Arsenic Trioxide in Small Cell Lung Cancer
Arsenic Trioxide - Lung Cancer, Cancer of Lung
Phase 2CompletedEmory University202011-08-012021-02-17
LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy
YM155 - Lung Cancer, Cancer of Lung
Phase 2CompletedAstellas Pharma Inc372006-12-012008-01-02

Narrower conditions

Lung Neoplasms (4)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Carcinoma, Small Cell (1)  ·  Colorectal Neoplasms (1)  ·  Mesothelioma (1)  ·  Mesothelioma, Malignant (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)

Broader conditions

Lung Diseases (4)  ·  Neoplasms by Site (4)  ·  Respiratory Tract Diseases (4)  ·  Respiratory Tract Neoplasms (4)  ·  Thoracic Neoplasms (4)  ·  Neoplasms (3)  ·  Bronchial Neoplasms (2)  ·  Carcinoma, Bronchogenic (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Adenoma (1)  ·  Carcinoma (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)

Interventions

Arsenic Trioxide (1)  ·  Ipilimumab (1)  ·  JDQ443 (1)  ·  Nivolumab (1)  ·  UV1 vaccine (1)  ·  sargramostim (1)  ·  sepantronium (1)  ·  tislelizumab (1)

Sponsors

Astellas Pharma Inc (1)  ·  Emory University (1)  ·  Novartis Pharmaceuticals (1)  ·  Åslaug Helland (1)

Countries

Australia (2)  ·  Denmark (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Spain (2)  ·  United States (2)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  France (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Japan (1)  ·  Norway (1)

Top investigators

Taofeek Owonikoko, MD, PhD (1)

Results publications

PMID 27142472, PMID 34059094, PMID 36399068, PMID 39133306, PMID 42322509

NIH funding

K23CA164015 (1)